-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
-
Summary
-
ELITE PHARMACEUTICALS INC /NV/ quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q2 2019 to Q3 2025.
- ELITE PHARMACEUTICALS INC /NV/ Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Sep 2025 was $306,134.000, a 38.5% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)